Cardiac arrest and dysrhythmias
›Resuscitation pathway
›ACLS per current AHA guidance
›Early defibrillation for VF or pulseless VT
›High quality CPR with minimal interruptions
›Respiratory arrest focus
›Assisted ventilation to prevent secondary hypoxic arrest
›Early airway placement when feasible
›Post ROSC bundle
›SpO2 94 to 98 percent
›PaCO2 35 to 45 mmHg
›MAP 65 mmHg or higher
›Unstable bradycardia
›Atropine
›Atropine IV 1 mg
›Repeat every 3 to 5 minutes
›Maximum 3 mg
›Transcutaneous pacing
›Symptomatic bradycardia refractory to atropine
›Sedation if time and perfusion allow
›Epinephrine infusion
›Epinephrine IV infusion 2 to 10 microg per minute
›Titrate to perfusion targets
›Continuous ECG monitoring
›Narrow complex tachycardia
›Adenosine
›Adenosine IV 6 mg rapid push
›Second dose 12 mg rapid push
›Avoid in irregular wide complex rhythm
›Ventricular dysrhythmia
›Amiodarone for VF or pulseless VT refractory to shocks
›Amiodarone IV 300 mg
›Additional dose 150 mg
›Follow with infusion per ACLS protocol
›Magnesium for torsades
›Magnesium sulfate IV 2 g
›Repeat dosing per recurrence
›QT prolongation correction strategy
Rhabdomyolysis and kidney protection
›Fluid strategy
›Isotonic crystalloid
›Normal saline IV bolus 10 to 20 ml per kg for hypovolemia
›Maintenance infusion guided by urine output
›Urine output targets
›Adults 1 to 2 ml per kg per hour
›Pediatrics 1 to 2 ml per kg per hour
›Electrolyte management
›Hyperkalemia protocol if potassium elevation mmol/l
›Calcium gluconate IV 3 g
›Repeat for persistent ECG changes
›Continuous ECG monitoring
›Insulin regular IV 10 units
›Dextrose IV 25 g
›Glucose recheck every 30 to 60 minutes
›Salbutamol inhaled 10 to 20 mg nebulized
›Tachycardia monitoring
›Additive to insulin effect
›Hypocalcemia
›Avoid routine calcium replacement in rhabdomyolysis unless symptomatic
›Calcium replacement for seizures or arrhythmia
›Compartment syndrome mitigation
›Limb elevation at heart level
›Avoid excessive elevation with ischemia concern
›Frequent neurovascular checks
›Surgical consultation triggers
›Progressive pain with passive stretch
›Diminishing pulses not due to vasospasm
›Burn care basics
›Cooling and cleaning
›Cool running water for superficial thermal burns
›Avoid ice application
›Dressings
›Nonadherent dressing for partial thickness burns
›Moist wound environment
›Tetanus prophylaxis
›Tdap if not up to date
›TIG for unknown or incomplete vaccination with dirty wound
›Burn center referral triggers
›Full thickness burn
›Any size
›High risk functional areas
›Hands feet face genitalia major joints
›Specialized care requirement
›Functional outcome risk
›Circumferential extremity burn
›Escharotomy consideration
›Distal ischemia risk
›Infection prevention
›Systemic antibiotics
›Not routine for uncomplicated burns
›Indicated for cellulitis or invasive infection signs
Pain control and sedation
›Analgesia options
›Acetaminophen
›Acetaminophen PO 1000 mg
›Maximum 4000 mg per 24 hours
›Lower maximum in liver disease
›Ibuprofen
›Ibuprofen PO 400 mg
›Repeat every 6 hours
›Avoid in significant AKI risk
›Fentanyl
›Fentanyl IV 25 microg
›Repeat every 5 to 10 minutes
›Titrate to pain control
›Morphine
›Morphine IV 2 mg
›Repeat every 5 to 10 minutes
›Avoid in hypotension
›Agitation and procedures
›Ketamine
›Ketamine IV 0.2 mg per kg
›Repeat dosing for analgesia
›Airway monitoring
›Midazolam
›Midazolam IV 1 mg
›Repeat every 2 to 3 minutes
›Respiratory depression monitoring
Eye and ear injury management
›Eye care
›Irrigation for debris exposure
›Normal saline until symptom relief
›Fluorescein exam for abrasion
›Ophthalmology consultation triggers
›Decreased visual acuity
›Hyphema
›Suspected globe injury
›Delayed complications counseling
›Cataract risk
›Retinal injury risk
›Ear care
›Tympanic membrane rupture
›Keep ear dry
›Avoid otic drops unless prescribed
›ENT referral triggers
›Vertigo
›Facial weakness
›Persistent hearing loss